News | July 06, 2022
Regeneron completes purchase of Sanofi's stake in Libtayo
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
Company provides anticipated impact to second quarter 2022 financial results due to recently completed business development transactions
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
The AICVD tool can predict the risk of cardiovascular disease.
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
Medicines, including insulin, to be available in 40 lower-income countries
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Earlier initiation with Kesimpta resulted in a more than three-fold increased likelihood of maintaining NEDA-3 throughout the study
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
Strengthens investment in channels of the future to expand patient reach
Subscribe To Our Newsletter & Stay Updated
